Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability

Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Olimulder, M. A. G. M. [verfasserIn] Galjee, M. A. [verfasserIn] van Es, J. [verfasserIn] Wagenaar, L. J. [verfasserIn] von Birgelen, C. [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2011

Schlagwörter:	Contrast enhancement Cardiovascular magnetic resonance imaging Cardiac involvement Cardiomyopathy Tissue characterisation

Übergeordnetes Werk:	Enthalten in: Netherlands heart journal - [S.l.] : PubMed Central, 2001, 19(2011), 5 vom: 03. März, Seite 236-245
Übergeordnetes Werk:	volume:19 ; year:2011 ; number:5 ; day:03 ; month:03 ; pages:236-245

Links:	Volltext

DOI / URN:	10.1007/s12471-011-0084-6

Katalog-ID:	SPR025713418

Internformat


LEADER	01000caa a22002652 4500
001	SPR025713418
003	DE-627
005	20230519173823.0
007	cr uuu---uuuuu
008	201007s2011 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s12471-011-0084-6 \|2 doi
035			\|a (DE-627)SPR025713418
035			\|a (SPR)s12471-011-0084-6-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q ASE
100	1		\|a Olimulder, M. A. G. M. \|e verfasserin \|4 aut
245	1	0	\|a Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
264		1	\|c 2011
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability.
650		4	\|a Contrast enhancement \|7 (dpeaa)DE-He213
650		4	\|a Cardiovascular magnetic resonance imaging \|7 (dpeaa)DE-He213
650		4	\|a Cardiac involvement \|7 (dpeaa)DE-He213
650		4	\|a Cardiomyopathy \|7 (dpeaa)DE-He213
650		4	\|a Tissue characterisation \|7 (dpeaa)DE-He213
700	1		\|a Galjee, M. A. \|e verfasserin \|4 aut
700	1		\|a van Es, J. \|e verfasserin \|4 aut
700	1		\|a Wagenaar, L. J. \|e verfasserin \|4 aut
700	1		\|a von Birgelen, C. \|e verfasserin \|4 aut
773	0	8	\|i Enthalten in \|t Netherlands heart journal \|d [S.l.] : PubMed Central, 2001 \|g 19(2011), 5 vom: 03. März, Seite 236-245 \|w (DE-627)53467299X \|w (DE-600)2365465-X \|x 1876-6250 \|7 nnns
773	1	8	\|g volume:19 \|g year:2011 \|g number:5 \|g day:03 \|g month:03 \|g pages:236-245
856	4	0	\|u https://dx.doi.org/10.1007/s12471-011-0084-6 \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 19 \|j 2011 \|e 5 \|b 03 \|c 03 \|h 236-245

Indexfelder

author_variant	m a g m o magm magmo m a g ma mag e j v ej ejv l j w lj ljw b c v bc bcv
matchkey_str	article:18766250:2011----::otatnacmncricantceoaciaigeo
hierarchy_sort_str	2011
publishDate	2011
allfields	10.1007/s12471-011-0084-6 doi (DE-627)SPR025713418 (SPR)s12471-011-0084-6-e DE-627 ger DE-627 rakwb eng 610 ASE Olimulder, M. A. G. M. verfasserin aut Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability. Contrast enhancement (dpeaa)DE-He213 Cardiovascular magnetic resonance imaging (dpeaa)DE-He213 Cardiac involvement (dpeaa)DE-He213 Cardiomyopathy (dpeaa)DE-He213 Tissue characterisation (dpeaa)DE-He213 Galjee, M. A. verfasserin aut van Es, J. verfasserin aut Wagenaar, L. J. verfasserin aut von Birgelen, C. verfasserin aut Enthalten in Netherlands heart journal [S.l.] : PubMed Central, 2001 19(2011), 5 vom: 03. März, Seite 236-245 (DE-627)53467299X (DE-600)2365465-X 1876-6250 nnns volume:19 year:2011 number:5 day:03 month:03 pages:236-245 https://dx.doi.org/10.1007/s12471-011-0084-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 19 2011 5 03 03 236-245
spelling	10.1007/s12471-011-0084-6 doi (DE-627)SPR025713418 (SPR)s12471-011-0084-6-e DE-627 ger DE-627 rakwb eng 610 ASE Olimulder, M. A. G. M. verfasserin aut Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability. Contrast enhancement (dpeaa)DE-He213 Cardiovascular magnetic resonance imaging (dpeaa)DE-He213 Cardiac involvement (dpeaa)DE-He213 Cardiomyopathy (dpeaa)DE-He213 Tissue characterisation (dpeaa)DE-He213 Galjee, M. A. verfasserin aut van Es, J. verfasserin aut Wagenaar, L. J. verfasserin aut von Birgelen, C. verfasserin aut Enthalten in Netherlands heart journal [S.l.] : PubMed Central, 2001 19(2011), 5 vom: 03. März, Seite 236-245 (DE-627)53467299X (DE-600)2365465-X 1876-6250 nnns volume:19 year:2011 number:5 day:03 month:03 pages:236-245 https://dx.doi.org/10.1007/s12471-011-0084-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 19 2011 5 03 03 236-245
allfields_unstemmed	10.1007/s12471-011-0084-6 doi (DE-627)SPR025713418 (SPR)s12471-011-0084-6-e DE-627 ger DE-627 rakwb eng 610 ASE Olimulder, M. A. G. M. verfasserin aut Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability. Contrast enhancement (dpeaa)DE-He213 Cardiovascular magnetic resonance imaging (dpeaa)DE-He213 Cardiac involvement (dpeaa)DE-He213 Cardiomyopathy (dpeaa)DE-He213 Tissue characterisation (dpeaa)DE-He213 Galjee, M. A. verfasserin aut van Es, J. verfasserin aut Wagenaar, L. J. verfasserin aut von Birgelen, C. verfasserin aut Enthalten in Netherlands heart journal [S.l.] : PubMed Central, 2001 19(2011), 5 vom: 03. März, Seite 236-245 (DE-627)53467299X (DE-600)2365465-X 1876-6250 nnns volume:19 year:2011 number:5 day:03 month:03 pages:236-245 https://dx.doi.org/10.1007/s12471-011-0084-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 19 2011 5 03 03 236-245
allfieldsGer	10.1007/s12471-011-0084-6 doi (DE-627)SPR025713418 (SPR)s12471-011-0084-6-e DE-627 ger DE-627 rakwb eng 610 ASE Olimulder, M. A. G. M. verfasserin aut Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability. Contrast enhancement (dpeaa)DE-He213 Cardiovascular magnetic resonance imaging (dpeaa)DE-He213 Cardiac involvement (dpeaa)DE-He213 Cardiomyopathy (dpeaa)DE-He213 Tissue characterisation (dpeaa)DE-He213 Galjee, M. A. verfasserin aut van Es, J. verfasserin aut Wagenaar, L. J. verfasserin aut von Birgelen, C. verfasserin aut Enthalten in Netherlands heart journal [S.l.] : PubMed Central, 2001 19(2011), 5 vom: 03. März, Seite 236-245 (DE-627)53467299X (DE-600)2365465-X 1876-6250 nnns volume:19 year:2011 number:5 day:03 month:03 pages:236-245 https://dx.doi.org/10.1007/s12471-011-0084-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 19 2011 5 03 03 236-245
allfieldsSound	10.1007/s12471-011-0084-6 doi (DE-627)SPR025713418 (SPR)s12471-011-0084-6-e DE-627 ger DE-627 rakwb eng 610 ASE Olimulder, M. A. G. M. verfasserin aut Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability. Contrast enhancement (dpeaa)DE-He213 Cardiovascular magnetic resonance imaging (dpeaa)DE-He213 Cardiac involvement (dpeaa)DE-He213 Cardiomyopathy (dpeaa)DE-He213 Tissue characterisation (dpeaa)DE-He213 Galjee, M. A. verfasserin aut van Es, J. verfasserin aut Wagenaar, L. J. verfasserin aut von Birgelen, C. verfasserin aut Enthalten in Netherlands heart journal [S.l.] : PubMed Central, 2001 19(2011), 5 vom: 03. März, Seite 236-245 (DE-627)53467299X (DE-600)2365465-X 1876-6250 nnns volume:19 year:2011 number:5 day:03 month:03 pages:236-245 https://dx.doi.org/10.1007/s12471-011-0084-6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 19 2011 5 03 03 236-245
language	English
source	Enthalten in Netherlands heart journal 19(2011), 5 vom: 03. März, Seite 236-245 volume:19 year:2011 number:5 day:03 month:03 pages:236-245
sourceStr	Enthalten in Netherlands heart journal 19(2011), 5 vom: 03. März, Seite 236-245 volume:19 year:2011 number:5 day:03 month:03 pages:236-245
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Contrast enhancement Cardiovascular magnetic resonance imaging Cardiac involvement Cardiomyopathy Tissue characterisation
dewey-raw	610
isfreeaccess_bool	true
container_title	Netherlands heart journal
authorswithroles_txt_mv	Olimulder, M. A. G. M. @@aut@@ Galjee, M. A. @@aut@@ van Es, J. @@aut@@ Wagenaar, L. J. @@aut@@ von Birgelen, C. @@aut@@
publishDateDaySort_date	2011-03-03T00:00:00Z
hierarchy_top_id	53467299X
dewey-sort	3610
id	SPR025713418
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR025713418</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519173823.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2011 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12471-011-0084-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR025713418</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12471-011-0084-6-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Olimulder, M. A. G. M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Contrast enhancement</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular magnetic resonance imaging</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiac involvement</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiomyopathy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue characterisation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galjee, M. A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Es, J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wagenaar, L. J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Birgelen, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Netherlands heart journal</subfield><subfield code="d">[S.l.] : PubMed Central, 2001</subfield><subfield code="g">19(2011), 5 vom: 03. März, Seite 236-245</subfield><subfield code="w">(DE-627)53467299X</subfield><subfield code="w">(DE-600)2365465-X</subfield><subfield code="x">1876-6250</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:5</subfield><subfield code="g">day:03</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:236-245</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12471-011-0084-6</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2011</subfield><subfield code="e">5</subfield><subfield code="b">03</subfield><subfield code="c">03</subfield><subfield code="h">236-245</subfield></datafield></record></collection>
author	Olimulder, M. A. G. M.
spellingShingle	Olimulder, M. A. G. M. ddc 610 misc Contrast enhancement misc Cardiovascular magnetic resonance imaging misc Cardiac involvement misc Cardiomyopathy misc Tissue characterisation Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
authorStr	Olimulder, M. A. G. M.
ppnlink_with_tag_str_mv	@@773@@(DE-627)53467299X
format	electronic Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut aut aut aut aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	1876-6250
topic_title	610 ASE Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability Contrast enhancement (dpeaa)DE-He213 Cardiovascular magnetic resonance imaging (dpeaa)DE-He213 Cardiac involvement (dpeaa)DE-He213 Cardiomyopathy (dpeaa)DE-He213 Tissue characterisation (dpeaa)DE-He213
topic	ddc 610 misc Contrast enhancement misc Cardiovascular magnetic resonance imaging misc Cardiac involvement misc Cardiomyopathy misc Tissue characterisation
topic_unstemmed	ddc 610 misc Contrast enhancement misc Cardiovascular magnetic resonance imaging misc Cardiac involvement misc Cardiomyopathy misc Tissue characterisation
topic_browse	ddc 610 misc Contrast enhancement misc Cardiovascular magnetic resonance imaging misc Cardiac involvement misc Cardiomyopathy misc Tissue characterisation
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Netherlands heart journal
hierarchy_parent_id	53467299X
dewey-tens	610 - Medicine & health
hierarchy_top_title	Netherlands heart journal
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)53467299X (DE-600)2365465-X
title	Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
ctrlnum	(DE-627)SPR025713418 (SPR)s12471-011-0084-6-e
title_full	Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
author_sort	Olimulder, M. A. G. M.
journal	Netherlands heart journal
journalStr	Netherlands heart journal
lang_code	eng
isOA_bool	true
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2011
contenttype_str_mv	txt
container_start_page	236
author_browse	Olimulder, M. A. G. M. Galjee, M. A. van Es, J. Wagenaar, L. J. von Birgelen, C.
container_volume	19
class	610 ASE
format_se	Elektronische Aufsätze
author-letter	Olimulder, M. A. G. M.
doi_str_mv	10.1007/s12471-011-0084-6
dewey-full	610
author2-role	verfasserin
title_sort	contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
title_auth	Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
abstract	Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability.
abstractGer	Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability.
abstract_unstemmed	Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	5
title_short	Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability
url	https://dx.doi.org/10.1007/s12471-011-0084-6
remote_bool	true
author2	Galjee, M. A. van Es, J. Wagenaar, L. J. von Birgelen, C.
author2Str	Galjee, M. A. van Es, J. Wagenaar, L. J. von Birgelen, C.
ppnlink	53467299X
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1007/s12471-011-0084-6
up_date	2024-07-03T17:10:29.769Z
_version_	1803578643340853248
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR025713418</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519173823.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2011 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12471-011-0084-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR025713418</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12471-011-0084-6-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Olimulder, M. A. G. M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The clinical applications of cardiovascular magnetic resonance imaging with contrast enhancement are expanding. Besides the direct visualisation of viable and non-viable myocardium, this technique is increasingly used in a variety of cardiac disorders to determine the exact aetiology, guide proper treatment, and predict outcome and prognosis. In this review, we discuss the value of cardiovascular magnetic resonance imaging with contrast enhancement in a range of cardiac disorders, in which this technique may provide insights beyond the scope of myocardial viability.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Contrast enhancement</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular magnetic resonance imaging</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiac involvement</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiomyopathy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue characterisation</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galjee, M. A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van Es, J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wagenaar, L. J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Birgelen, C.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Netherlands heart journal</subfield><subfield code="d">[S.l.] : PubMed Central, 2001</subfield><subfield code="g">19(2011), 5 vom: 03. März, Seite 236-245</subfield><subfield code="w">(DE-627)53467299X</subfield><subfield code="w">(DE-600)2365465-X</subfield><subfield code="x">1876-6250</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:5</subfield><subfield code="g">day:03</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:236-245</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12471-011-0084-6</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2011</subfield><subfield code="e">5</subfield><subfield code="b">03</subfield><subfield code="c">03</subfield><subfield code="h">236-245</subfield></datafield></record></collection>
score	7.401573

Nicht das Richtige dabei?

Schreiben Sie uns!

Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?